Search
Search filters
Type
Audience
Category
Issue
Last updated
- 20231 results available
- 20222 results available
- 20218 results available
- 20191 results available
- 20181 results available
- 20162 results available
- 20151 results available
- 20141 results available
- 20131 results available
- 20124 results available
- 20092 results available
- 20074 results available
- 20065 results available
- 20057 results available
- 20044 results available
- 20032 results available
- 20025 results available
- 20011 results available
Recall class
Displaying 31 - 45 of 52 items.
Important Safety Information on Xylocaine (Lidocaine HCI) Jelly 2% Single Use Plastic Syringe (10 mL): Update Notice to Hospitals
AlertHealth professional risk communication | 2007-08-07
Archived - Important Safety Concerns re Use of Propofol for Sedation in Pediatric Patients
AlertHealth professional risk communication | 2001-05-01
Safety information regarding topical anesthetics and serious adverse events - For Health Professionals
AlertHealth professional risk communication | 2009-03-05
Archived - Association of CRESTOR
AlertHealth professional risk communication | 2005-03-08
Archived – Important Safety Information Regarding Casodex 150 mg – Accelerated Deaths in Localized Prostate Cancer Patients – For the Public
AlertHealth professional risk communication | 2003-08-26
Lynparza® (2018-02-23)
RecallHealth product recall | 2018-02-23
Xylocaine (lidocaine HCl)
AlertHealth professional risk communication | 2006-12-06
Health Canada update on the tamoxifen shortage
AlertInformation update | 2019-11-20
FASLODEX (fulvestrant) - Risk of Unnecessary Therapy Modification due to Falsely Elevated Estradiol Levels
AlertHealth professional risk communication | 2016-10-18
Important Safety Information Regarding Reports of Serious Hepatic Events in Patients Receiving ACCOLATE® (Zafirlukast) – For Health Professionals
AlertHealth professional risk communication | 2004-04-19
Archived – Updated safety information regarding Crestor
AlertPublic advisory | 2004-11-24
Archived - Accelerated deaths using Casodex® (bicalutamide) 150 mg in patients with localized prostate cancer
AlertHealth professional risk communication | 2003-08-26
SGLT2 Inhibitors [INVOKANA (canagliflozin), FORXIGA (dapagliflozin), XIGDUO (dapagliflozin/metformin), JARDIANCE (empagliflozin)] - Risk of Diabetic Ketoacidosis
AlertHealth professional risk communication | 2016-05-16
MULTISTIX 10SG (2015-06-24)
RecallHealth product recall | 2015-08-11
Archive - Safety Information about a Class of Asthma Drugs Known as Long-Acting Beta-2 Agonists
AlertPublic advisory | 2005-10-04